Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
Dendritic cells (DCs) are the primary antigen-presenting cells and play key roles in the orchestration of the innate and adaptive immune system. Targeting DCs by nanotechnology stands as a promising strategy for cancer immunotherapy. The physicochemical properties of nanoparticles (NPs) influence th...
Main Authors: | Jianbo Jia, Yi Zhang, Yan Xin, Cuijuan Jiang, Bing Yan, Shumei Zhai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00404/full |
Similar Items
-
Between biology and medicine: perspectives on the use of dendritic cells in anticancer therapy
by: Agnieszka Szczygieł, et al.
Published: (2017-11-01) -
Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
by: Anne Huber, et al.
Published: (2018-12-01) -
Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
by: Simone P. Sittig, et al.
Published: (2015-12-01) -
Harnessing human cross-presenting CLEC9A+XCR1+ dendritic cells for immunotherapy
by: Kirsteen eTullett, et al.
Published: (2014-05-01) -
Fetotoxicity of Nanoparticles: Causes and Mechanisms
by: Chuanfeng Teng, et al.
Published: (2021-03-01)